SCHEMBL22018237

SCHEMBL22018237

C=Cc1c(NN)ncc(NC(=O)c2ccccccccc2)c1C1CCCCCCCC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADCY1 Q08828 2/20 0.42
CCR8 P51685 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HDAC1 Q13547 2/20 0.38
KDM1A O60341 1/20 0.37
ATR Q13535 1/20 0.37
HDAC2 Q92769 2/20 0.36
NAMPT P43490 1/20 0.36
DEGS1 O15121 1/20 0.36
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TP53 P04637 1/20 0.35
SERPINE1 P05121 2/20 0.35
ADCY8 P40145 1/20 0.35
HDAC3 O15379 1/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18399591 0.83 HDAC3 (0.45) HDAC1HDAC2NPC1RAB9AHDAC3
SCHEMBL18399529 0.74 MALT1 (0.52) ADCY1CCR8KDM4E
SCHEMBL18399589 0.72 HDAC3 (0.42) HDAC1HDAC2NPC1RAB9AHDAC3
SCHEMBL18399586 0.72 PARP1 (0.47) ADCY1CCR8KDM4ENPC1RAB9A
SCHEMBL22853573 0.72 HDAC3 (0.42) HDAC1HDAC2NPC1RAB9AHDAC3
SCHEMBL22018149 0.71 KDM4E (0.50) ADCY1KDM4EHDAC1HDAC2NAMPT
SCHEMBL22018420 0.71 KDM4E (0.50) ADCY1CCR8KDM4EHDAC2NAMPT
SCHEMBL21157772 0.71 ADCY1 (0.44) ADCY1CCR8KDM4EHDAC1NAMPT
SCHEMBL18399571 0.70 ADCY1 (0.46) ADCY1CCR8KDM4EHDAC1NAMPT
SCHEMBL18399585 0.69 ADCY1 (0.42) ADCY1CCR8KDM4EHDAC1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 ADCY1 1867/4885CCR8 3259/4885KDM4E 913/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 ADCY1 1867/4885CCR8 3259/4885KDM4E 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.